Follow the latest coverage, related explainers and connected technology stories.
CDRH has launched a reference portal explaining regulatory reliance programs for assessments and decisions by other regulatory authorities, focusing on using FDA data without transferring decision-making responsibility or reducing safety requirements. The portal provides guidance on verifying the identity of devices and their manufacturing sites and monitoring post-market safety.
The U.S. Food and Drug Administration (FDA) explains the regulatory and design standards that manufacturers of over-the-counter medical devices should consider, from usability and labeling to clinical evidence and connected software. It also explains when a new 510(k), De Novo request, or PMA application may be required when converting a device from prescription use to direct-to-consumer use.